The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome

    December 2022
    Mohamed Kandil
    Image of study
    TLDR Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.
    The commentary by Mohamed Kandil proposes a reclassification of Polycystic Ovary Syndrome (PCOS), a hormonal disorder common in women of reproductive age. Kandil suggests renaming it to "Polyfollicular Anovulatory Androgenic Syndrome" (PAAS) to better reflect its symptoms of multiple follicles in the ovaries, lack of ovulation, and high male hormone levels. He also proposes three other names for less severe forms of the syndrome: "Anovulatory Androgenic Syndrome", "Polyfollicular Androgenic Syndrome", and "Polyfollicular Anovulatory Syndrome". However, concerns are raised that the new name may not fully cover all complex metabolic abnormalities associated with the syndrome, such as obesity, acne, alopecia, hirsutism, and depression. The new naming system could enhance research efforts, but further consideration of the syndrome's full range of symptoms is needed.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results